8FMJ image
Entry Detail
PDB ID:
8FMJ
Keywords:
Title:
Crystal structure of human KRAS in space group R32
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2022-12-23
Release Date:
2023-11-22
Method Details:
Experimental Method:
Resolution:
1.33 Å
R-Value Free:
0.16
R-Value Work:
0.14
R-Value Observed:
0.14
Space Group:
H 3 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:GTPase KRas
Mutations:C118S
Chain IDs:A
Chain Length:176
Number of Molecules:1
Biological Source:Homo sapiens
Primary Citation
Crystal Packing Reveals a Potential Autoinhibited KRAS Dimer Interface and a Strategy for Small-Molecule Inhibition of RAS Signaling.
Biochemistry 62 3206 3213 (2023)
PMID: 37938120 DOI: 10.1021/acs.biochem.3c00378

Abstact

KRAS GTPases harbor oncogenic mutations in more than 25% of human tumors. KRAS is considered to be largely undruggable due to the lack of a suitable small-molecule binding site. Here, we report a unique crystal structure of His-tagged KRASG12D that reveals a remarkable conformational change. The Switch I loop of one His-KRASG12D structure extends into the Switch I/II pocket of another His-KRASG12D in an adjacent unit cell to create an elaborate interface that is reminiscent of high-affinity protein-protein complexes. We explore the contributions of amino acids at this interface using alanine-scanning studies with alchemical free energy perturbation calculations based on explicit-solvent molecular dynamics simulations. Several interface amino acids were found to be hot spots as they contributed more than 1.5 kcal/mol to the protein-protein interaction. Computational analysis of the complex revealed the presence of two large binding pockets that possess physicochemical features typically found in pockets considered druggable. Small-molecule binding to these pockets may stabilize this autoinhibited structure of KRAS if it exists in cells to provide a new strategy to inhibit RAS signaling.

Legend

Protein

Chemical

Disease

Primary Citation of related structures